PCAT-1: A novel oncogenic long non-coding RNA in human cancers

51Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

Abstract

Long non-coding RNAs (lncRNAs) are transcripts longer than 200 nucleotides (nts) without obvious protein coding potential. lncRNAs act as multiple roles in biological processes of diseases, especially carcinomas. Prostate cancer associated transcript-1 (PCAT-1) is an oncogenic lncRNA that identified by RNA-Sequence in prostate cancer. High expression of PCAT-1 is observed in different types of cancers, including prostate cancer, colorectal cancer, hepatocellular cancer and gastric cancer. High expressed PCAT-1 is correlated with poor overall survival. Furthermore, PCAT-1 regulates cancer cell proliferation, apoptosis, migration and invasion. Additionally, PCAT-1 is involved in EMT and Wnt/β-catenin-signaling pathway. In this review, we focus on the implication of PCAT-1 in human cancers.

Cite

CITATION STYLE

APA

Xiong, T., Li, J., Chen, F., & Zhang, F. (2019). PCAT-1: A novel oncogenic long non-coding RNA in human cancers. International Journal of Biological Sciences. Ivyspring International Publisher. https://doi.org/10.7150/ijbs.30970

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free